The global meningococcal vaccines market is expected to reach US$ 4.4 billion by 2022, registering a CAGR of 12% during the forecast period. Reshaping of the global health and development by developing countries is primarily driving the meningococcal vaccines market. Various non-profit organizations play an important role in educating and spreading awareness through various activities. In addition, travel vaccines for meningococcal disease and convenient public-private partnerships to support the development of vaccines at low cost are expected to fuel the growth of the market. However, disparate age groups and prescribed regimen for routine immunization as well as the unpredictable and dynamic epidemiology of meningococcal disease are expected to hamper the growth of the market. The maintenance of cold chains to deliver vaccines results in the high cost of vaccination which is also restraining the growth of the market.
Early buyers will receive customization of the report as per requirement.
In this report, the global meningococcal vaccines market is segmented by type and region. Based on type, the market is segmented into polysaccharide vaccines, conjugate vaccines, combination vaccines, and Men B vaccines. Each type is further segmented by brand. The polysaccharide vaccines segment includes Menomune, Mencevax, NmVac4, and others (Quadri Mening and Bi Meningo). The conjugate vaccines segment by brand includes Menactra, Menveo, NeisVac-C, Nimenrix, Meningitec, Menjugate, MenAfriVac, and NmVac4-DT. The combination vaccines segment includes MenHibrix and Menitorix. The Men B vaccines segment by brand includes Bexsero and Trumenba.
A glimpse of the report structure is provided in the report description available on the website.
The global meningococcal vaccines market is also segmented on the basis of key regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Furthermore, each region is segmented to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, India, Brazil, and GCC countries. The report includes a detailed study of global and regional meningococcal vaccines market and analyzes the variations in the growth of the industry in certain regions.
Most Active Players in The Meningococcal Vaccines Market
Pfizer, JN-International Medical Corporation, Novartis International AG, GlaxoSmithKline Plc, Sanofi S.A. Inc., Serum Institute of India Ltd., and Nuron Biotech are the most active players in the meningococcal vaccines market.
Scope of the Report
This report covers the meningococcal vaccines market, in terms of value, and forecasts the market size till 2022. It includes the market segmentation by type and region. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the market share and company profiles of the key players in the global market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact firstname.lastname@example.org